Product Name
CYP21A2, cDNA Clone
Full Product Name
CYP21A2 cDNA Clone
Product Gene Name
CYP21A2 cdna clone
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Sequence
ATGCTGCTCC TGGGCCTGCT GCTGCTGCTG CCCCTGCTGG CTGGCGCCCG CCTGCTGTGG AACTGGTGGA AGCTCCAGAG CCTCCACCTC CCGCCTCTTG CCCCGGGCTT CTTGCACTTG CTGCAGCCCG ACCTCCCAAT CTATCTGCTT GGCCTGACTC AGAAATTCGG GCCCATCTAC AGGCTCCACC TTGGGCTGCA AGATGTGGTG GTGCTGAACT CCAAGAGGAC CATTGAGGAA GCCATGGTCA AAAAGTGGGC AGACTTTGCT GGCAGACCTG AGCCACTTAC CTACAAGCTG GTGTCTAGGA ACTACCCGGA CCTGTCCTTG GGAGACTACT CCCTGCTCTG GAAAGCCCAC AAGAAGCTCA CCCGCTCAGC CCTGCTGCTG GGCATCCGTG ACTCCATGGA GCCAGTGGTG GAGCAGCTGA CCCAGGAGTT CTGTGAGCGC ATGAGAGCCC AGCCCGGCAC CCCTGTGGCC ATTGAGGAGG AATTCTCTCT CCTCACCTGC AGCATCATCT GTTACCTCAC CTTCGGAGAC AAGATCAAGG ACGACAACTT AATGCCTGCC TATTACAAAT GTATCCAGGA GGTGTTAAAA ACCTGGAGCC ACTGGTCCAT CCAAATTGTG GACGTGATTC CCTTTCTCAG GTTCTTCCCC AATCCAGGTC TCCGGAGGCT GAAGCAGGCC ATAGAGAAGA GGGATCACAT CGTGGAGATG CAGCTGAGGC AGCACAAGGA GAGCCTCGTG GCAGGCCAGT GGAGGGACAT GATGGACTAC ATGCTCCAAG GGGTGGCGCA GCCGAGCATG GAAGAGGGCT CTGGACAGCT CCTGGAAGGG CACGTGCACA TGGCTGCAGT GGACCTCCTG ATCGGTGGCA CTGAGACCAC AGCAAACACC CTCTCCTGGG CCGTGGTTTT TTTGCTTCAC CACCCTGAGA TTCAGCAGCG ACTGCAGGAG GAGCTAGACC ACGAACTGGG CCCTGGTGCC TCCAGCTCCC GGGTCCCCTA CAAGGACCGT GCACGGCTGC CCTTGCTCAA TGCCACCATC GCCGAGGTGC TGCGCCTGCG GCCCGTTGTG CCCTTAGCCT TGCCCCACCG CACCACACGG CCCAGCAGCA TCTCCGGCTA CGACATCCCT GAGGGCACAG TCATCATTCC GAACCTCCAA GGCGCCCACC TGGATGAGAC GGTCTGGGAG AGGCCACATG AGTTCTGGCC TGATCGCTTC CTGGAGCCAG GCAAGAACTC CAGAGCTCTG GCCTTCGGCT GCGGTGCCCG CGTGTGCCTG GGCGAGCCGC TGGCGCGCCT GGAGCTCTTC GTGGTGCTGA CCCGACTGCT GCAGGCCTTC ACGCTGCTGC CCTCCGGGGA CGCCCTGCCC TCCCTGCAGC CCCTGCCCCA CTGCAGTGTC ATCCTCAAGA TGCAGCCTTT CCAAGTGCGG CTGCAGCCCC GGGGGATGGG GGCCCACAGC CCGGGCCAGA GCCAGTGA
ISO Certification
Manufactured in an ISO 13485:2003 and EN ISO 13485:2012 Certified Laboratory.
Other Notes
Small volumes of CYP21A2 cdna clone vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
NCBI/Uniprot data below describe general gene information for CYP21A2. It may not necessarily be applicable to this product.
NCBI Accession #
BC125181
[Other Products]
UniProt Secondary Accession #
P04033; Q01204; Q08AG8; Q16749; Q16806; Q5ST44; Q96NU8; A2BHY6[Other Products]
UniProt Related Accession #
P08686[Other Products]
Molecular Weight
52,597 Da
NCBI Official Full Name
Homo sapiens cytochrome P450, family 21, subfamily A, polypeptide 2, mRNA
NCBI Official Synonym Full Names
cytochrome P450 family 21 subfamily A member 2
NCBI Official Symbol
CYP21A2??[Similar Products]
NCBI Official Synonym Symbols
CAH1; CPS1; CA21H; CYP21; CYP21B; P450c21B
??[Similar Products]
NCBI Protein Information
steroid 21-hydroxylase
UniProt Protein Name
Steroid 21-hydroxylase
UniProt Synonym Protein Names
21-OHase; Cytochrome P-450c21; Cytochrome P450 21; Cytochrome P450 XXI; Cytochrome P450-C21; Cytochrome P450-C21B
UniProt Gene Name
CYP21A2??[Similar Products]
UniProt Synonym Gene Names
CYP21; CYP21B??[Similar Products]
UniProt Entry Name
CP21A_HUMAN
NCBI Summary for CYP21A2
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
UniProt Comments for CYP21A2
CYP21A2: Specifically catalyzes the 21-hydroxylation of steroids. Required for the adrenal synthesis of mineralocorticoids and glucocorticoids. Defects in CYP21A2 are the cause of adrenal hyperplasia type 3 (AH3). AH3 is a form of congenital adrenal hyperplasia, a common recessive disease due to defective synthesis of cortisol. Congenital adrenal hyperplasia is characterized by androgen excess leading to ambiguous genitalia in affected females, rapid somatic growth during childhood in both sexes with premature closure of the epiphyses and short ***** stature. Four clinical types: 'salt wasting' (SW, the most severe type), 'simple virilizing' (SV, less severely affected patients), with normal aldosterone biosynthesis, 'non-classic form' or late onset (NC or LOAH), and 'cryptic' (asymptomatic). Belongs to the cytochrome P450 family.
Protein type: Oxidoreductase; Lipid Metabolism - C21-steroid hormone; EC 1.14.99.10
Chromosomal Location of Human Ortholog: 6p21.3
Cellular Component: endoplasmic reticulum membrane
Molecular Function: heme binding; steroid 21-monooxygenase activity; steroid hydroxylase activity
Biological Process: glucocorticoid biosynthetic process; mineralocorticoid biosynthetic process; steroid biosynthetic process; steroid metabolic process; sterol metabolic process
Disease: Adrenal Hyperplasia, Congenital, Due To 21-hydroxylase Deficiency
Research Articles on CYP21A2
1. G variation in the Z promoter is involved in misregulating the transcriptional activity of the CYP21A2 gene.">The results suggest that the A>G variation in the Z promoter is involved in misregulating the transcriptional activity of the CYP21A2 gene.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.